BRAF and breast cancer: Idylla detected BRAF V600 mutations in 12 of 30 melanomas (40%), 1 of 23 colorectal cancers (4%), and 2 of 5 papillary thyroid cancers (40%) but did not detect BRAF V600 mutations in breast cancers or NSCLC.